Intermittent hypoxia, such as that associated with obstructive sleep apnea, can cause neuronal death and neurobehavioral dysfunction. The cellular and molecular mechanisms through which hypoxia alter hippocampal function are incompletely understood. ] enkephalin (DAMGO) was ordered by the degree of hypoxia such that sustained hypoxia > intermittent hypoxia > room air. Carbachol increased G protein activation during sustained hypoxia (38%), intermittent hypoxia (29%), and room air (27%). DAMGO also activated G proteins during sustained hypoxia (52%), intermittent hypoxia (48%), and room air (43%). Region-specific comparisons of G protein activation revealed that the DG showed significantly less activation by carbachol following intermittent hypoxia and sustained hypoxia than the CA1. Considered together, the results suggest the potential for hypoxia to alter hippocampal function by blunting the cholinergic activation of G proteins within the DG. V
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ABSTRACT:
Intermittent hypoxia, such as that associated with obstructive sleep apnea, can cause neuronal death and neurobehavioral dysfunction. The cellular and molecular mechanisms through which hypoxia alter hippocampal function are incompletely understood. This study used in vitro [ 35 S]guanylyl-5 0 -O-(c-thio)-triphosphate ([ 35 S]GTPcS) autoradiography to test the hypothesis that carbachol and DAMGO activate hippocampal G proteins. In addition, this study tested the hypothesis that in vivo exposure to different oxygen (O 2 ) concentrations causes a differential activation of G proteins in the CA1, CA3, and dentate gyrus (DG) regions of the hippocampus. G protein activation was quantified as nCi/g tissue in CA1, CA3, and DG from rats housed for 14 days under one of three different oxygen conditions: normoxic (21% O 2 ) room air, or hypoxia (10% O 2 ) that was intermittent or sustained. Across all regions of the hippocampus, activation of G proteins by the cholinergic agonist carbachol and the mu opioid agonist [D-Ala 2 , NMet-Phe 4 , Gly 5 ] enkephalin (DAMGO) was ordered by the degree of hypoxia such that sustained hypoxia > intermittent hypoxia > room air. Carbachol increased G protein activation during sustained hypoxia (38%), intermittent hypoxia (29%), and room air (27%). DAMGO also activated G proteins during sustained hypoxia (52%), intermittent hypoxia (48%), and room air (43%). Region-specific comparisons of G protein activation revealed that the DG showed significantly less activation by carbachol following intermittent hypoxia and sustained hypoxia than the CA1. Considered together, the results suggest the potential for hypoxia to alter hippocampal function by blunting the cholinergic activation of G proteins within the DG. V
INTRODUCTION
Obstructive sleep apnea (OSA) is characterized by repeated obstruction of the upper airway during sleep and results in episodes of intermittent hypoxia and sleep fragmentation (Ryan and Bradley, 2005 ). An estimated 12-18 million people in the United States have sleep apnea, with a higher prevalence in men (4%) than in women (2%) and OSA is associated with risk factors such as age, excessive weight, and high blood pressure (Young et al., 1993) . In OSA patients, hypoxic events can occur 20-30 times per hour with cessation of breathing lasting for 10-20 s or more (Shamsuzzaman et al., 2003) . Daytime symptoms of OSA include excessive sleepiness and neurobehavioral impairment (Engleman and Joffe, 1999; Beebe, 2005; Walker and Stickgold, 2006) . Research concerning the effects of intermittent hypoxia has been stimulated by efforts to understand the impact of hypoxia on sleep, learning, and memory (Ninomiya et al., 1989; Greenberg et al., 1999; Gozal et al., 2001a; Hamrahi et al., 2001; Gozal et al., 2002; Goldbart et al., 2003a,b; Row et al., 2003; Zhao et al., 2005) .
The hippocampus is vulnerable to hypoxia (Yamaoka et al., 1993; Matsuoka et al., 1997; Gozal et al., 2001a,b) and intermittent hypoxia alters the excitability of hippocampal neurons (Schiff and Somjen, 1985) . Cholinergic neurotransmission contributes to hippocampal function (Colom et al., 1991) , and muscarinic cholinergic receptors are expressed by hippocampal neurons (Satoh and Kaneko, 1994; Rouse et al., 1999; van der Zee and Luiten, 1999) . Muscarinic cholinergic receptors are G protein coupled (reviewed in Caulfield and Birdsall, 1998) , and carbachol activates muscarinic cholinergic receptors and G proteins in brain regions regulating sleep (Capece et al., 1998a; DeMarco et al., 2003; Douglas et al., 2004) . Activated G proteins can be labeled using [ (Sim et al., 1995) . The hippocampus also contains endogenous opioids (Watson et al., 1982) and mu opioid receptors (Crain et al., 1986; Mansour et al., 1987; Tempel and Zukin, 1987; Drake and Milner, 2002) . Mu opioid receptors are coupled to G proteins (Corbett et al., 2006) , providing a key rationale for the present use of the mu opioid receptor agonist [D-Ala ] enkephalin (DAMGO). G proteins in brain regions regulating sleep are activated by DAMGO (Capece et al., 1998b; Tanase et al., 2001; Bernard et al., 2006) . Many studies have shown that activating mu opioid receptors can have excitatory actions throughout the hippocampus (Zieglgansberger et al., 1979; Dunwiddie et al., 1980; Siggins and Zieglgansberger, 1981; Mayer et al., 1994; Mayer and Henriksen, 1995) . Hippocampal mu opioid receptors have a region-specific distribution and contribute to normal hippocampal function (Svodoba et al., 1999; Drake and Milner, 2002) .
No previous studies have quantified the effect of hypoxia on cholinergic or opioid activation of G proteins in rat hippocampus. Therefore, the present study was designed to test the hypothesis that carbachol and DAMGO activate hippocampal G proteins. In addition, this study tested the hypothesis that these changes in G protein activation are modulated by different hypoxic treatments (intermittent and sustained hypoxia) in the CA1, CA3, and dentate gyrus (DG) regions of the hippocampus. Portions of these results have been presented in abstract form (Hambrecht et al., 2006) .
MATERIALS AND METHODS
Overview of Study Design
During 14 days of in vivo treatment, rats were exposed to either room air, intermittent hypoxia, or sustained hypoxia. On protocol day 15, rats in all three groups were decapitated and brains were removed and frozen for a subsequent biochemical assay that makes it possible to quantify agonist-stimulated G protein activation in a brain region-specific manner (Sim et al., 1995 (Sim et al., , 1997 Harrison and Traynor, 2003) . This in vitro assay (described below) focused on G proteins in the CA1, CA3, and DG regions of the hippocampus. Brain sections were assayed for G protein activation using in vitro conditions that quantified basal, carbachol-and DAMGO-stimulated [ 35 S]GTPgS binding. Figure 1A provides a schematic overview of the study design.
Animals and In Vivo Treatment
All experiments were conducted in accordance with the Public Health Service policy on Humane Care and Use of Schematic of study design and techniques used to quantify G protein activation in the hippocampus. (A) Outlines the in vivo and in vitro phases of this study. During the initial in vivo phase, rats underwent one of the three treatments involving 14 days of exposure to room air, intermittent hypoxia, or sustained hypoxia. For the following in vitro phase of the study, rats were decapitated and brains were removed and immediately frozen. Brains were sectioned serially and the hippocampus was assayed for G protein activation by the cholinergic agonist carbachol and the mu opioid receptor agonist DAMGO. Basal levels of [ Laboratory Animals (National Institutes of Health Publication 80-23). Before starting the experiment, groups of up to 6 adult male Sprague-Dawley rats (Charles River Laboratories, Wilmington, MA), 45-50 days old, were housed in identical chambers (30 3 20 3 20 cubic in) under normoxic conditions and in a 12:12 h light-dark cycle (lights on at 6:00 A.M.). Ambient temperature was maintained at 22-248C. Air circulation for each chamber was set at 60 L/min, resulting in one complete air turnover every 10 s. To begin an experiment, rats were exposed for 14 days to one of three different O 2 concentrations, as described previously (Gozal et al., 2001a) . O 2 concentration was monitored throughout the entire experiment and adjusted automatically if necessary. The intermittent hypoxia group (n 5 6) experienced alternating 10% O 2 and 21% O 2 every 90 s for 12 h during the light phase, and room air for 12 h during the dark phase. Rats in the sustained hypoxia group (n 5 5) were exposed to hypoxic air (10% O 2 ) throughout the 12 h of the light phase, and room air during the dark phase. Control animals (n 5 6) were exposed to normoxic (21% O 2 ) room air 24 h per day. After 14 days animals were decapitated and brains were removed and frozen in a 2308C bilayer of bromobutane (Fisher Scientific, Boston, MA) and isopentane (SigmaAldrich, St. Louis, MO) to prevent distortion. The favorable homology of this rodent model of sleep disordered breathing has been validated (Gozal et al., 2001a; Hamrahi et al., 2001) .
Tissue Preparation and In Vitro [ 35 S]GTPcS Autoradiography
Coronal brain sections (20 lm) that included the hippocampus (bregma 22.30 to 24.30 mm) (Paxinos and Watson, 1998) were cut serially using a Leica CM 3050 S cryostat (Leica Microsystems, Nussloch, Germany). Adjacent pairs of sections were thaw-mounted on gelatin-coated glass slides. The slides were dried in a vacuum desiccator (48C) and stored in a 2808C freezer until used in the [
35 S]GTPgS assay. (DeMarco et al., 2003; Douglas et al., 2004) . Slide mounted brain sections were removed from the freezer and slowly brought to room temperature. All tissue sections were rinsed in assay buffer (50 mM Tris-HCl, 3 mM MgCl 2 , 0.2 mM EGTA, and 100 mM NaCl, pH 7.4) for 10 min. All sections were preincubated for 15 min in a solution containing assay buffer, 2 mM GDP, and 2 U/mg ADA. One group of tissue sections was then incubated for 2 h in assay buffer containing 0.04 nM [ 35 S]GTPgS, 2 mM GDP, 2 U/mg ADA, and the cholinergic agonist carbachol (1 mM). Basal binding was measured in the absence of carbachol using a second group of tissue sections. A third set of tissue sections was incubated in assay buffer containing the mu opioid agonist DAMGO (3 lM). Excess unlabeled GTPgS (10 lM) was used with a fourth group of brain sections to evaluate nonspecific binding. Incubation was terminated by rinsing the sections twice in ice-cold 50 mM TrisHCl buffer (pH 7.0) for 2 min and once in deionized ice-cold water for 30 s. Tissue sections then were dried at 48C under a stream of air. Sections were placed in a vacuum desiccator at room temperature overnight to complete the drying process. Sections and 14 C microscale standards (31-883 nCi/g, Amersham Biosciences, Arlington Heights, IL) were packed in autoradiography cassettes containing Kodak BioMax MR film (Fisher Scientific, Boston, MA). The film was exposed for 16 h to the slide-mounted tissue sections and radioactive standards before being developed using a Kodak X-OMAT Model 2002A film processor. Tissue sections were fixed with paraformaldehyde vapor (808C) and stained with cresyl violet.
Quantification of [ 35 S]GTPcS Binding
The assay described earlier produced autoradiographic images of hippocampal sections from each of the 17 brains studied. As a result of the exchange with GDP, the nonhydrolyzable [ 35 S]GTPgS remained bound to the receptor-G protein complex. Thus, the increase in radioactivity and corresponding increase in optical density provided a quantitative index of G protein activation (Sim et al., 1995; Harrison and Traynor, 2003) . The autoradiographic images and the cresyl violetstained tissue sections from which they were derived were digitized using a Cohu CCD camera with a Nikon 60 mm objective. The digitized images were analyzed using a G3 Macintosh computer running the Scion Image 1.62c version of the NIH Image program. Figures 1B,C illustrate the procedure for accurately localizing each hippocampal region (CA1, CA3, and DG) on a digitized image of a cresyl violet-stained tissue section. The x-y coordinates of the localized region were then transferred to the corresponding autoradiographic image, from which the optical density measurements were made. These measurements represent total binding. The present results summarize 9,180 data points of the type illustrated in Figure 1C . As previously described (Capece et al., 1998a; DeMarco et al., 2003; Douglas et al., 2004 ) the data were averaged to provide a mean for each animal, then averaged across animals for statistical comparisons. This statistically conservative approach circumvents issues of pseudo-replication and inflated degrees of freedom. The animal mean data were analyzed using repeated measures analysis of variance (ANOVA) and non-parametric Kruskal-Wallis test. Post-hoc comparisons were performed using Tukey-Kramer multiple comparisons test and t-test. A probability value of P 0.05 was set as statistically significant.
RESULTS
Cholinergic-and Opioid-Stimulated G Protein Activation
Color-coded autoradiograms (Fig. 2) (Fig. 3A) and the CA3 region (Fig. 3B ) carbachol significantly (P < 0.01) increased [
35 S]GTPgS binding over basal binding values for the room air, intermittent hypoxia, and sustained hypoxia conditions. Figure 3C shows that within the DG carbachol caused Carbachol activated G proteins in the hippocampus. (A) Coronal atlas plate from Paxinos and Watson (1998) showing the three different measurement areas (CA1, CA3, and DG) in the rat hippocampus. The boxed area on the left is enlarged on the right to the same scale as the color-coded autoradiograms in (B), (C), and (D). Compared to basal levels of G protein activation, carbachol significantly activated G proteins following room air (B), intermittent hypoxia (C), and sustained hypoxia (D) conditions. a significant (P < 0.01) increase in G protein activation for the room air and sustained hypoxia groups. In contrast, carbachol did not significantly increase [
35 S]GTPgS binding in the DG from rats exposed to intermittent hypoxia (Fig. 3C) .
DAMGO caused a significant (P < 0.001) activation of hippocampal G proteins compared to basal levels (Figs. 3D-F) . Furthermore, activation of G proteins by DAMGO was always greater than activation caused by carbachol. In contrast to carbachol, DAMGO significantly (P < 0.01) increased [ 35 S]GTPgS binding in the DG for all three in vivo oxygen conditions (Fig. 3F) 
Activation of G Proteins in the CA1, CA3, and DG
G protein activation by in vivo O 2 condition and in vitro carbachol and DAMGO treatment is plotted in Figure 4 as a function of hippocampal region. For the room air-carbachol group (Fig. 4A) , repeated measures one-way ANOVA showed no significant difference in G protein activation as a function of hippocampal region. For animals treated with intermittent hypoxia (Fig. 4B) , ANOVA revealed a significant difference in carbachol-stimulated G protein activation (F 5 5.79; df 5 2, 12; P 5 0.02). Tukey-Kramer multiple comparisons test indicated that [ 35 S]GTPgS binding was significantly lower in the DG than in the CA1. For the different hippocampal areas from the sustained hypoxia condition (Fig. 4C ), ANOVA indicated a Carbachol-and DAMGO-stimulated G protein activation as a function of hippocampal region for each of the three in vivo treatment conditions. (A) Rats exposed to room air (RA) showed no significant differences in carbachol-stimulated region-specific difference in G protein activation (F 5 4.44; df 5 2, 10; P 5 0.05). A significantly lower [ 35 S]GTPgS binding level for DG compared to CA1 was confirmed by a TukeyKramer multiple comparisons test. In contrast to the carbachol results, DAMGO-stimulated G protein activation did not show any significant differences when analyzed as a function of hippocampal regions (Figs. 4D-F) .
DISCUSSION
Carbachol Differentially Activated G Proteins in CA1, CA3, and DG
The present finding that the cholinergic agonist carbachol significantly increased G protein activation in rat hippocampus (Figs. 2 and 3) is consistent with the significant increases in [ 35 S]GTPgS binding in the vertical and horizontal limbs of the diagonal band of Broca, medial and lateral septum, and nucleus basalis/substantia innominata caused by carbachol (Douglas et al., 2004) . The G protein data agree also with the longstanding hypothesis that cholinergic neurotransmission plays a major role in hippocampal function (Deutsch, 1971) .
Cholinergic activation of G proteins varied significantly across different regions of the hippocampus (Fig. 4) . The differences in G protein activation between DG and CA1 were small but statistically significant (Figs. 4B,C) . Even small changes in cholinergic signaling can be physiologically relevant. For example, the hippocampus shares reciprocal connections with the prefrontal cortex (Beebe and Gozal, 2002) where even a 15% increase in acetylcholine (ACh) release causes a physiologically significant activation of the electroencephalogram (Douglas et al., 2002) .
The Figure 4 data show that intermittent hypoxia and sustained hypoxia caused significantly lower carbachol-stimulated G protein activation in the DG than in the CA1. The present data do not address the mechanisms causing the lower level of G protein activation in DG. This result is of interest in view of the continuous neurogenesis in the DG (Zhu et al., 2005; Christie and Cameron, 2006; Wiskott et al., 2006) . The cyclic AMP response element binding protein (CREB) is critical for neurogenesis and hippocampal CREB can be modulated by hypoxia . There might also be fewer muscarinic cholinergic receptors in the DG. The decreased G protein activation in DG associated with hypoxia (Fig. 4) is consistent with previous studies showing that hypoxia disrupts rat sleep (Hamrahi et al., 2001 ) and with the finding that sleep deprivation causes decreased cell proliferation in rat DG (Guzmán-Marín et al., 2003) .
Hypoxia Did Not Alter Opioid-Induced Activation of Hippocampal G proteins
Mu opioid receptors, similar to muscarinic cholinergic receptors, are coupled to G proteins and can be visualized using the [ 35 S]GTPgS assay (Sim et al., 1995; Capece et al., 1998b) . The significant increase in [
35 S]GTPgS caused by DAMGO (Figs. 3D-F) provides a positive control for the activation of G proteins by carbachol (Figs. 3A-C) . The hypothesis that hypoxia alters DAMGO-stimulated G protein activation was drawn from previous evidence showing that mu opioid receptor activation of G proteins can change with experience. For example, chronic heroin administration causes a 61% decrease in DAMGO-stimulated [
35 S]GTPgS binding within hippocampus (Sim-Selley et al., 2000) . The current results did not support the hypothesis that intermittent or sustained hypoxia altered activation of hippocampal G proteins by DAMGO.
Acetylcholine, Sleep, and Hippocampal Function
There is compelling evidence that ACh contributes to hippocampal-dependent learning and memory (Hasselmo and Schnell, 1994; Vizi and Kiss, 1998; Hasselmo, 1999; Hasselmo and McClelland, 1999; Rouse et al., 1999; van der Zee and Luiten, 1999; Rogers and Kesner, 2003) and ACh levels in the hippocampus increase during memory consolidation (Power et al., 2003) . The view that sleep contributes to memory consolidation (Smith, 1985 (Smith, , 1996 Stickgold et al., 2001; Staba et al., 2002; Datta et al., 2004; Walker and Stickgold, 2006) is directly relevant to the current focus on cholinergic activation of hippocampal G proteins. Cholinergic neurotransmission is involved in generating rapid eye movement (REM) sleep , hypoxia disrupts REM sleep in human (Ryan and Bradley, 2005) and rat (Hamrahi et al., 2001) , and ACh release in the hippocampus increases during REM sleep (Marrosu et al., 1995) . Basal forebrain neurons provide ACh to the hippocampus and ACh release in the basal forebrain is maximal during the REM phase of sleep (Vazquez and Baghdoyan, 2001) . A memory consolidating role for sleep is also consistent with electrophysiological data from rat (Wilson and McNaughton, 1994) and human (Staba et al., 2002) documenting hippocampal CA1 place cell firing patterns during sleep that replicate discharge sequences previously recorded during wakefulness. In contrast to sleep facilitating learning, sleep deprivation leads to impaired executive control and poor performance on vigilance tasks (Decary et al., 2000; Horstmann et al., 2000) . In rat, sleep deprivation impairs hippocampalmediated contextual learning (Ruskin et al., 2004) and selective REM sleep deprivation impairs learning of a spatial navigational task (Bjorness et al., 2005) .
Limitations and Conclusions
The [ 35 S]GTPgS assay was limited to a single concentration of carbachol (1 mM) demonstrated by previous studies to be ideal for detecting G proteins activated by muscarinic cholinergic receptors (Capece et al., 1998b; DeMarco et al., 2003; Douglas et al., 2004) . Likewise, the present study used a single concentration of DAMGO (3 lM), shown previously to activate G proteins by mu opioid receptors (Capece et al., 1998b; DeMarco et al., 2003) . There are no purely subtype selective muscarinic agonists and the present study permits no conclusions regarding subtypes of muscarinic cholinergic receptors mediating the response to carbachol. The exposure to hypoxia in the present study was limited to a single time interval of 14 days. The ability of hypoxia to modulate hippocampal G protein activation may vary as a function of duration of hypoxic exposure. There are further limitations in the inability of the present study to specify the type of G proteins activated by carbachol or DAMGO. In general, the kinetics of the [ 35 S]GTPgS assay favor activation of inhibitory G proteins (Harrison and Traynor, 2003; Bernard et al., 2005 Bernard et al., , 2006 .
In spite of these limitations, the [ 35 S]GTPgS assay has two major advantages for studies of hippocampus (Sim-Selley et al., 2000; Hong and Werling, 2001 ). First, this assay provides the unique ability to localize G proteins while preserving brain anatomy (Harrison and Traynor, 2003; Bernard et al., 2005) . Thus, the colorized autoradiograms of Figure 2 precisely localize activated G proteins within the CA1, CA3, and DG regions of rat hippocampus. Second, by subtracting nonspecific binding from total binding, the assay provides a quantitative measure of specific [ (Figs. 3 and 4) . These two features made the [ 35 S]GTPgS assay ideal for testing the hypothesis that hypoxia alters G protein activation in the hippocampus.
S]GTPgS binding
In conclusion, three novel findings emerge from this study. First, compared to basal levels of G protein activation, the cholinergic agonist carbachol and the mu opioid agonist DAMGO significantly activated G proteins in the CA1, CA3, and the DG regions of the hippocampus. Second, the magnitude of G protein activation by DAMGO was greater than activation caused by carbachol, and G protein activation by DAMGO was not altered by hypoxia. Third, quantifying agonist activation of G proteins as a function of hippocampal region showed that intermittent hypoxia and sustained hypoxia caused significantly lower levels of G protein activation by carbachol in the DG than in CA1. These results suggest the potential for hypoxia to alter hippocampal function by blunting the cholinergic activation of G proteins within the DG.
